We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
(+14%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
9.66%
Top 10 Holdings %
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$197M |
| 2 |
Alibaba
BABA
|
+$190M |
| 3 |
Amazon
AMZN
|
+$161M |
| 4 |
GoDaddy
GDDY
|
+$135M |
| 5 |
Walt Disney
DIS
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 2 |
Zoetis
ZTS
|
+$96.3M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$69.5M |
| 4 |
Cadence Design Systems
CDNS
|
+$64.2M |
| 5 |
ANSS
Ansys
ANSS
|
+$60.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.88% |
| 2 | Consumer Discretionary | 23.99% |
| 3 | Technology | 11.1% |
| 4 | Financials | 8.14% |
| 5 | Industrials | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Curtiss-Wright
CW
$27.5B
| $1.48M | 0.01% |
11,620
+11,044
| +1,917% | +$1.27M |
|
|
RCM
852
DELISTED
R1 RCM Inc. Common Stock
RCM
| $1.46M | 0.01% |
115,661
+114,561
| +10,415% | +$1.29M |
|
853
Seres Therapeutics
MCRB
$47M
| $1.44M | 0.01% |
22,335
+16,205
| +264% | +$1.54M |
|
854
Spectrum Brands
SPB
$2.04B
| $1.44M | 0.01% |
26,706
+26,696
| +266,960% | +$1.59M |
|
|
OPTU
855
Optimum Communications Inc
OPTU
$298M
| $1.43M | 0.01% |
58,826
-619,223
| -91% | -$14.7M |
|
|
KREF
856
KKR Real Estate Finance Trust
KREF
$471M
| $1.43M | 0.01% |
71,904
+43,152
| +150% | +$872K |
|
|
CDK
857
DELISTED
CDK Global, Inc.
CDK
| $1.42M | 0.01% |
+28,725
| New | +$1.54M |
|
858
Eaton
ETN
$155B
| $1.42M | 0.01% |
17,031
+5,274
| +45% | +$427K |
|
859
Monster Beverage
MNST
$93.2B
| $1.4M | 0.01% |
43,996
-518,918
| -92% | -$15.6M |
|
860
German American Bancorp
GABC
$1.83B
| $1.4M | 0.01% |
46,567
+11,702
| +34% | +$344K |
|
|
DHIL
861
DELISTED
Diamond Hill
DHIL
| $1.38M | 0.01% |
9,760
+5,857
| +150% | +$836K |
|
|
DISCK
862
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $1.34M | 0.01% |
47,200
+34,924
| +284% | +$948K |
|
863
iShares MSCI Turkey ETF
TUR
$203M
| $1.33M | 0.01% |
+55,977
| New | +$1.28M |
|
864
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
| $1.33M | 0.01% |
48,271
+9,636
| +25% | +$261K |
|
865
Bausch Health
BHC
$1.67B
| $1.32M | 0.01% |
+52,529
| New | +$1.25M |
|
|
AIMC
866
DELISTED
Altra Industrial Motion Corp
AIMC
| $1.32M | 0.01% |
36,705
-171,325
| -82% | -$5.91M |
|
867
Citi Trends
CTRN
$543M
| $1.3M | 0.01% |
89,139
+41,480
| +87% | +$710K |
|
868
Ring Energy
REI
$297M
| $1.3M | 0.01% |
399,587
+364,229
| +1,030% | +$1.62M |
|
869
Las Vegas Sands
LVS
$31.6B
| $1.3M | 0.01% |
+21,938
| New | +$1.36M |
|
|
MDR
870
DELISTED
McDermott International
MDR
| $1.29M | 0.01% |
+133,686
| New | +$1.07M |
|
871
Heron Therapeutics
HRTX
$86.9M
| $1.28M | 0.01% |
68,904
+68,701
| +33,843% | +$1.37M |
|
|
HTZ
872
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $1.28M | 0.01% |
80,199
-853,841
| -91% | -$12.9M |
|
873
MSCI
MSCI
$41.5B
| $1.27M | 0.01% |
5,332
-123,193
| -96% | -$27.6M |
|
|
LNW
874
DELISTED
Light & Wonder
LNW
| $1.27M | 0.01% |
+64,099
| New | +$1.33M |
|
875
Avis
CAR
$5.78B
| $1.25M | 0.01% |
+35,520
| New | +$1.19M |
|
Similar funds
Marshall Wace's Q2 2019 Portfolio in Review
As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.
- Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
- Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
- Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
- Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
- Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
- Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.
Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.